0,968  0,001  Antihypercholesterolemic
0,954  0,001  Cholesterol antagonist
0,896  0,004  Carcinogenic
0,891  0,007  Apoptosis agonist
0,880  0,003  Chemopreventive
0,880  0,006  Antiinflammatory
0,875  0,005  CYP3A4 substrate
0,868  0,004  Bone diseases treatment
0,870  0,008  Transcription factor NF kappa B inhibitor
0,857  0,006  Teratogen
0,840  0,004  Antiosteoporotic
0,830  0,007  Embryotoxic
0,810  0,004  Antipsoriatic
0,802  0,004  Hepatic disorders treatment
0,780  0,002  UGT1A4 substrate
0,769  0,003  Hair growth stimulant
0,754  0,004  NOS3 expression inhibitor
0,747  0,005  Lipoprotein disorders treatment
0,743  0,002  Antiparkinsonian, rigidity relieving
0,730  0,005  Nitric oxide antagonist
0,721  0,005  Caspase 3 stimulant
0,706  0,006  Proliferative diseases treatment
0,719  0,022  Caspase 9 stimulant
0,695  0,008  CYP2C19 substrate
0,675  0,008  Atherosclerosis treatment
0,669  0,006  Immunomodulator
0,673  0,012  Prostate cancer treatment
0,682  0,023  Antineoplastic (breast cancer)
0,664  0,004  Diuretic
0,660  0,002  Pregnane X receptor agonist
0,659  0,004  Anesthetic
0,653  0,003  Androgen antagonist
0,650  0,004  Hepatoprotectant
0,663  0,018  Cyclophilin D inhibitor
0,663  0,018  Antidiabetic
0,658  0,017  TNF expression inhibitor
0,639  0,004  Anesthetic general
0,639  0,007  Antineoplastic (brain cancer)
0,632  0,003  UGT2B4 substrate
0,641  0,012  Antineoplastic (ovarian cancer)
0,642  0,014  Respiratory analeptic
0,627  0,001  Cholesterol synthesis inhibitor
0,630  0,005  Hypolipemic
0,621  0,008  UGT1A6 substrate
0,632  0,020  Antileukemic
0,629  0,026  Antineoplastic (lung cancer)
0,617  0,018  Antiobesity
0,598  0,004  Prostatic (benign) hyperplasia treatment
0,597  0,011  Antineoplastic (pancreatic cancer)
0,594  0,012  Cytotoxic
0,582  0,007  UGT1A1 substrate
0,582  0,010  Antineoplastic (glioma)
0,580  0,008  UDP-glucuronosyltransferase substrate
0,586  0,015  Immunosuppressant
0,576  0,014  Antipruritic, allergic
0,567  0,011  Antifungal
0,570  0,017  Sensitization
0,552  0,002  Sodium/bile acid cotransporter inhibitor
0,561  0,014  Apoptosis antagonist
0,550  0,003  UGT2B7 substrate
0,548  0,003  Antihyperlipoproteinemic
0,571  0,028  Alzheimer's disease treatment
0,546  0,004  Interferon gamma antagonist
0,558  0,018  Chemoprotective
0,552  0,013  Antidiabetic (type 2)
0,544  0,009  Antineoplastic (glioblastoma multiforme)
0,538  0,004  Contraceptive
0,533  0,007  Antineoplastic (renal cancer)
0,530  0,005  Phospholipase C inhibitor
0,529  0,005  Antiacne
0,523  0,008  Interleukin agonist
0,527  0,014  Metabolic disease treatment
0,515  0,004  Prostate disorders treatment
0,513  0,005  Liver fibrosis treatment
0,510  0,002  Liver X receptor alpha agonist
0,507  0,002  Hyperparathyroidism treatment
0,502  0,004  DNA polymerase I inhibitor
0,522  0,032  CYP2C9 substrate
0,505  0,022  Analeptic
0,502  0,020  Antioxidant
0,481  0,005  UGT2B1 substrate
0,476  0,003  UGT2B9 substrate
0,477  0,004  Interleukin 4 antagonist
0,506  0,039  Antibacterial
0,486  0,020  NOS2 expression inhibitor
0,464  0,006  Sulfotransferase substrate
0,461  0,004  Antiinfertility, female
0,458  0,004  Neurotrophic factor
0,459  0,008  Abortion inducer
0,462  0,016  Renal disease treatment
0,456  0,014  Antineoplastic (liver cancer)
0,457  0,021  ICAM1 expression inhibitor
0,438  0,003  Farnesoid X receptor antagonist
0,438  0,010  Skin whitener
0,487  0,060  Antineoplastic (solid tumors)
0,432  0,005  Antiviral (Influenza A)
0,431  0,005  Neurotrophic factor enhancer
0,456  0,030  Antineoplastic (melanoma)
0,442  0,017  Antihypertriglyceridemic
0,451  0,027  Antihypertensive
0,431  0,007  Antipruritic, non-allergic
0,426  0,007  Lipocortins synthesis antagonist
0,418  0,002  5-Alpha-reductase inhibitor
0,428  0,022  Antineoplastic (lymphoma)
0,411  0,009  Antiviral (Influenza)
0,405  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,404  0,004  Contraceptive female
0,408  0,008  Protein-tyrosine phosphatase inhibitor
0,437  0,040  Immunostimulant
0,405  0,011  UGT1A3 substrate
0,405  0,020  Antineoplastic (endocrine cancer)
0,427  0,048  Antineoplastic (colorectal cancer)
0,402  0,027  Interleukin 2 agonist
0,416  0,047  Antineoplastic (colon cancer)
0,407  0,038  AR expression inhibitor
0,366  0,010  UGT2B15 substrate
0,359  0,005  Liver cirrhosis treatment
0,353  0,004  Choleretic
0,375  0,028  Amyotrophic lateral sclerosis treatment
0,353  0,010  Diabetic nephropathy treatment
0,366  0,030  Antiparasitic
0,373  0,043  CTGF expression inhibitor
0,362  0,035  Tumour necrosis factor alpha release inhibitor
0,346  0,023  Antihelmintic
0,317  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,347  0,034  Vascular (periferal) disease treatment
0,315  0,002  Anticholelithogenic
0,322  0,011  Acute respiratory distress syndrome (ARDS) treatment
0,357  0,050  Radioprotector
0,319  0,012  Growth factor agonist
0,352  0,052  Spasmolytic
0,303  0,009  Antineoplastic antibiotic
0,302  0,009  Autism spectrum disorders treatment
0,296  0,003  Bile acid receptor antagonist
0,308  0,016  Bone formation stimulant
0,295  0,005  UGT2B10 substrate
0,327  0,044  Hypoglycemic
0,317  0,043  Angiogenesis stimulant
0,326  0,053  UGT1A9 substrate
0,270  0,008  Anticataract
0,277  0,015  Insulin secretagoues
0,265  0,004  Hypercalcemia treatment
0,261  0,004  Liver X receptor agonist
0,303  0,051  Cardiodepressant
0,305  0,055  Antineoplastic (non-small cell lung cancer)
0,304  0,056  Antineoplastic (cervical cancer)
0,251  0,005  Arachidonic acid antagonist
0,271  0,028  Antieczematic atopic
0,238  0,004  Androgen agonist
0,237  0,005  CDC25A inhibitor
0,234  0,003  5-Alpha-reductase 2 inhibitor
0,260  0,030  Antiviral (Hepatitis)
0,297  0,068  Antineoplastic (multiple myeloma)
0,249  0,022  Hemostatic
0,312  0,092  Inflammatory Bowel disease treatment
0,233  0,013  Microtubule formation inhibitor
0,219  0,007  Inducible nitric-oxide synthase inhibitor
0,240  0,029  Protein kinase stimulant
0,216  0,006  Interleukin 2 antagonist
0,212  0,003  UGT2B11 substrate
0,210  0,007  Postmenopausal disorders treatment
0,236  0,036  Antiviral (Herpes)
0,217  0,016  Retinoprotector
0,204  0,004  Glycine receptor agonist
0,225  0,026  Antidiarrheal
0,251  0,054  Antineoplastic enhancer
0,199  0,004  Anabolic
0,196  0,005  Lanosterol 14 alpha demethylase inhibitor
0,193  0,003  RNA-directed RNA polymerase stimulant
0,221  0,032  Antiviral (Hepatitis C)
0,196  0,010  Actinic keratosis treatment
0,229  0,045  Muscle relaxant
0,184  0,002  Vitamin D receptor antagonist
0,184  0,003  Na+ K+ transporting ATPase inhibitor
0,198  0,017  Alcohol dehydrogenase substrate
0,272  0,093  Antimycobacterial
0,214  0,036  Phospholipase A2 inhibitor
0,178  0,003  5-Alpha-reductase 1 inhibitor
0,178  0,007  Paget's disease treatment
0,208  0,041  Amylase inhibitor
0,257  0,094  Hypoxia-inducible factor 1 alpha inhibitor
0,251  0,090  Antituberculosic
0,174  0,019  HDL-cholesterol increasing
0,153  0,001  Vitamin D receptor agonist
0,179  0,027  Adenylate cyclase stimulant
0,243  0,093  5 Hydroxytryptamine release stimulant
0,159  0,010  Estrogen agonist
0,154  0,007  Glycine receptor antagonist
0,149  0,003  Farnesoid X receptor agonist
0,231  0,087  Antineoplastic (sarcoma)
0,183  0,039  Antifungal enhancer
0,221  0,091  Cardiovascular analeptic
0,144  0,019  ABCA1 expression enhancer
0,168  0,043  Psychosexual dysfunction treatment
0,125  0,002  Parathyroid hormone antagonist
0,212  0,093  Antiprotozoal (Leishmania)
0,154  0,039  Growth stimulant
0,187  0,073  P-glycoprotein inhibitor
0,166  0,054  Skeletal muscle relaxant
0,190  0,078  Sedative
0,183  0,071  LDLR expression enhancer
0,229  0,119  CYP2D6 substrate
0,171  0,063  Interleukin 6 antagonist
0,206  0,103  Antidiabetic symptomatic
0,149  0,048  Antihemorrhagic
0,104  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,094  0,001  Hedgehog signaling activator
0,135  0,042  Expectorant
0,175  0,083  Systemic lupus erythematosus treatment
0,160  0,069  Melanin inhibitor
0,120  0,030  SULT1E1 substrate
0,115  0,026  Opioid kappa receptor antagonist
0,183  0,094  Interleukin antagonist
0,191  0,105  Free radical scavenger
0,092  0,008  Lipocortins synthesis agonist
0,120  0,038  Prolactin inhibitor
0,107  0,026  Vanilloid agonist
0,152  0,071  NOS3 expression enhancer
0,100  0,021  Aromatase inhibitor
0,122  0,043  Antineoplastic, alkylator
0,138  0,059  Cyclooxygenase 3 inhibitor
0,212  0,134  Antihypoxic
0,124  0,047  Estrogen antagonist
0,099  0,025  SULT1A2 substrate
0,103  0,033  Antibiotic
0,123  0,054  Endometrios treatment
0,073  0,004  Cholesterol absorption inhibitor
0,101  0,036  Contraceptive male
0,077  0,012  Acetyl-CoA transferase 2 inhibitor
0,102  0,037  Transcription factor NF kappa B stimulant
0,069  0,004  HMG CoA reductase inhibitor
0,075  0,012  Anesthetic inhalation
0,083  0,019  Acetyl-CoA transferase inhibitor
0,159  0,096  Platelet adhesion inhibitor
0,067  0,004  CYP24 inhibitor
0,172  0,110  Antiulcerative
0,067  0,006  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,125  0,066  Antiviral (Hepatitis B)
0,137  0,078  Lipid peroxidase inhibitor
0,120  0,061  Monophenol monooxygenase inhibitor
0,241  0,182  CYP2C19 inhibitor
0,127  0,072  Vanilloid 1 agonist
0,081  0,027  CDC25B inhibitor
0,071  0,021  Postcoital contraceptive
0,104  0,056  Estrogen receptor beta antagonist
0,139  0,092  Hexokinase inhibitor
0,153  0,106  Toxic, respiratory center
0,059  0,015  Microtubule stabilization
0,061  0,019  Aldosterone antagonist
0,107  0,067  Skin irritative effect
0,147  0,107  ATPase inhibitor
0,061  0,022  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,041  0,004  Ileal bile acid transport inhibitor
0,049  0,012  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,073  0,037  SULT2A1 substrate
0,057  0,022  Mineralocorticoid receptor antagonist
0,051  0,017  Estrogen receptor alpha agonist
0,106  0,072  SULT1A1 substrate
0,038  0,004  1,3-Beta-glucan synthase inhibitor
0,050  0,017  Acetyl-CoA transferase 1 inhibitor
0,033  0,001  Vitamin D-like
0,078  0,046  Antitreponemal
0,162  0,132  Antineoplastic (lymphocytic leukemia)
0,098  0,067  Protease inhibitor
0,063  0,033  Botulinum neurotoxin type A inhibitor
0,098  0,068  Hedgehog signaling inhibitor
0,163  0,133  VEGF expression inhibitor
0,151  0,123  Antirickettsial
0,181  0,152  Cardioprotectant
0,069  0,042  Andropause treatment
0,032  0,005  Apical sodium codependent bile acid transporter inhibitor
0,047  0,020  Estrogen receptor beta agonist
0,063  0,037  Heme oxygenase stimulant
0,173  0,147  Cardiotonic
0,043  0,018  Glucocorticoid antagonist
0,076  0,054  Estrogen receptor alpha antagonist
0,057  0,035  Angiotensin-converting enzyme inhibitor
0,085  0,063  Opioid antagonist
0,086  0,065  ATPase (Vacuolar H+) inhibitor
0,036  0,018  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,039  0,023  Progesterone antagonist
0,025  0,010  Corticosteroid-like
0,080  0,066  Antineoplastic alkaloid
0,021  0,007  Telomerase stimulant
0,015  0,002  Transcortin receptor antagonist
0,023  0,009  Progesterone agonist
0,159  0,146  Cytostatic
0,016  0,004  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,125  0,115  Antifungal (Cryptococcus)
0,089  0,080  Nitric-oxide synthase inhibitor
0,159  0,152  Heart failure treatment
0,033  0,027  Tubulin agonist
0,039  0,036  Hypogonadism treatment

